uBiome Stock
DNA sequencing
Sign up today and learn more about uBiome Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About uBiome Stock
uBiome is the world’s first effort to map the human microbiome with citizen science.
While the sequencing of the human genome has provided invaluable knowledge, it is very difficult to change their own genetic makeup. The microbiome, in contrast, is much more easily changed through simple means such as healthful probiotic cultures and other lifestyle interventions. The microbiome thus may provide some of the most important medical breakthroughs of their era. uBiome will ultimately empower participants to manage their microbiomes to improve their health as well as make important scientific discoveries for humanity.
Investors
Andreessen Horowitz
Lyft, Robinhood, Databricks, Airbnb, Instacart, Stripe, Magic Leap, Anduril Industries, Rappi, CoinSwitch Kuber
Funding History
July 2014 | $120K |
---|---|
August 2014 | $4.5M |
Management
Cofounder and CEO
Jessica Richman
Cofounder and CTO
Zachary Apte
Press
Forbes - Oct, 2 2019
Health Testing Startup UBiome Files For Chapter 7 With Plans To Shut DownWall Streets Journal - Sep, 6 2019
CVS to Stop Planned Sales of Bankrupt uBiome’s Explorer TestForbes - Sep, 4 2019
Health Test Company UBiome Has Filed For BankruptcyWall Streets Journal - Jul, 11 2019
VC Daily: VC Funds Keep Grabbing Cash; uBiome Fallout; SoftBank’s Latest South America DealWall Streets Journal - Jun, 30 2019
Lab-Testing Startup UBiome Shakes Up Leadership Again